Senior insider sale
XENON PHARMACEUTICALS INC. — senior position signals high conviction
$600.3K
13K shares
What this filing means
GANNON STEVEN plans to sell 13K shares of XENON PHARMACEUTICALS INC. valued at approximately $600.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/7/2024ACC: 0000950170-24-028231
13K
Shares to sell
$600.3K
Approx. market value
15K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Open Market Purchase
Cash
8/11/2017
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/11/2017 | Open Market Purchase Cash | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13K
Market value
$600.3K
3/7/2024
Total
Units
13K
Value
$600.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/7/2024 | 13K | $600.3K | NASDAQ | Planned |
| Total | 13K | $600.3K | ||